Resumen:
Joint replacement is rightfully considered one of the most techno-clinical success stories of the latter part of the 20th Century with numerous patients particularly those of advancing years having improved quality of life. Despite the latest range of materials having substantially improved wear characteristics that are reflected in the latest long-term studies, there have been several high-profile cases in which pre-clinically tested medical devices have failed in the body, catastrophically. The presentation will explore the role of standards, pre-clinical testing and why these failures might arise. Using his own substantial work in this area, the presentation will then demonstrate more advanced assessment scenarios and methodologies including the rise of in silico modelling as an important element of preclinical device assessment.
Biografía:
Professor Richard M. Hall is Professor of Biomechanical and Oncological Engineering in the Department of Mechanical Engineering at the University of Birmingham. His research sits at the interface of engineering and medicine, with a focus on MedTech for bone disease, particularly the spine and joint arthroplasty, and on developing realistic pre-clinical testing methodologies (including wear simulation and biotribology) to assess devices in conditions that better reflect real-world use. He has led and contributed to major international programmes and networks, including large-scale EU and EPSRC initiatives, and is associated with projects such as the €18.2M EU funded LifeLongJoints, BioTrib European Training Network and the Oncological Engineering programme grant, where he was the co-ordinator/principal investigator for all three activities. Prior to Birmingham, he was a Professor in the School of Mechanical Engineering at the University of Leeds.
He is a member of the School of Engineering Leadership Team with responsibility for People and Culture. He is also the lead for the Medical Engineering Cluster in the School. Externally he is a UK nominated expert on ISO Technical Committee 150 ‘Implants for Surgery’, where he provides input to standards development and review.